Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cancer news

Show

From To
Immunotherapy is safe and feasible in cancer patients treated for HIV, study suggests

Immunotherapy has been a major breakthrough in oncology -- but little is known about its safety for HIV-positive cancer patients. A study to be presented at the ESMO 2018 Congress in Munich has now provided data to suggest that treatment with PD-1/PD-L-1 immune checkpoint inhibitors, which target the very system affected by the HIV virus, is feasible in this patient population for whom cancer is currently one of the principal cause of mortality.

Published
22 October 2018
From
Eurekalert Inf Dis
HIV and cervical cancer – a perfect storm for women in Africa

Epidemics of HIV and HPV are inherently interconnected, and when they meet in the context of weak health systems, their effects serve to amplify each other.

Published
12 October 2018
From
Avert
US: HPV Vaccine Approved for Women and Men up to Age 45

On October 5, the Food and Drug Administration (FDA) expanded its approval of the Gardasil 9 vaccine, which protects against nine difference strains of human papillomavirus (HPV), to cover women and men ages 27 to 45.

Published
12 October 2018
From
Cancer Health
HIV/AIDS research yields dividends across medical fields

Nearly four decades of study has propelled advances in heart disease, hepatitis, cancer and other diseases.

Published
28 August 2018
From
Eurekalert Inf Dis
Largest oral HPV study in England shows infection rates lower than expected

Infection rates of high risk human papillomavirus (HR-HPV) oral infection in England are lower than expected, compared to previous US studies.

Published
20 August 2018
From
Eurekalert Inf Dis
Inovio Partners with AIDS Malignancy Consortium to Advance Inovio’s HPV Therapy for High-Grade Anal Dysplasia in HIV-positive Patients

AMC will fund a Phase 2 clinical trial to evaluate the efficacy of VGX-3100 in adult men and women with human papillomavirus (HPV)-related high-grade anal dysplasia or squamous intraepithelial lesions (ASIL) and HIV. Recruitment is already ongoing for patients who are HIV-positive with histologically confirmed anal high-grade squamous intraepithelial lesions (HSIL) associated with HPV-16 and/or HPV-18.

Published
07 August 2018
From
Inovio press release
Teenage boys to be vaccinated against cancer-causing HPV

Boys aged 12 and 13 in England are to be vaccinated against the cancer-causing human papilloma virus (HPV), the government has said.

Published
24 July 2018
From
The Guardian
HPV jab should be given to boys, committee says

Adolescent boys as well as girls should get the vaccine, an advisory committee says.

Published
18 July 2018
From
BBC Health
JCVI announcement on HPV vaccination for boys: HPV Action's press release

HPV Action welcomes today’s JCVI statement on HPV vaccination for boys and calls on the Department of Health and Social Care to accept the JCVI’s advice and without further delay announce that boys will be included in the national HPV vaccination programme.

Published
18 July 2018
From
HPV Action
Lung Cancer Incidence in HIV Remains High Years After Smoking Cessation

The incidence of lung cancer remains increased 5 years after smoking cessation in people with HIV, according to data published in Clinical Infectious Diseases.

Published
11 July 2018
From
Infectious Disease Advisor
← First12345...25Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.